Regulatory Mechanism for Biodiversity sector soon

February 16, 2012

A regulatory mechanism in Biodiversity sector to be in place following the recommendations

Objective: To safeguard public health and protect environment.
Quality Control lab in Delhi has been asked to bring wider range of bio-technology products under its ambit to ensure that they are safe and meet the prescribed standards.
Private sector requested to increase their presence in the research sector.
Central Government has approved Bio-Connect Centre for Bangalore which will be one of its kinds in the country, will assist mould young scientists as leaders in their specific fields of specialization.
40 such centres will come up gradually all over the India .
Supreme Court’s notice to Govt and Medical Council of India on alleged clinical trials of untested drugs
The Apex Court sought Centre’s response on a PIL seeking inquiry into alleged illegal clinical trials of untested drugs in various states.
Notice issued to the Health Ministry and Medical Council of India (MCI), seeking their replies on the petition.
Order issued on a PIL filed by an NGO, which sought appointment of an expert committee to regulate the clinical trials done by many multi-national pharmaceutical companies.
In the PIL it was pointed out that various Multi-national Pharma Companies are conducting illegal drug trials in India and such trials be stopped immediately and thus the SC’s intervention was sought in the matter.